Universe Pharmaceuticals (UPC) is trading down at $4.34 (-3.56%), as of the latest quote. It operates in the Health Care sector.
| FY2019Sep 2019 | FY2020Sep 2020 | FY2021Sep 2021 | FY2022Sep 2022 | FY2023Sep 2023 | FY2024Sep 2024 | FY2025Sep 2025 | |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $33.2M | $30.7M | $48.0M | $40.1M | $32.3B | $23.0B | $17.9B |
| Growth (year over year) | — | −7.6% | +56.3% | −16.3% | +80383.8% | −28.7% | −22.4% |
| Gross profit | $13.4M | $14.1M | $25.3M | $21.9M | $10.3B | $6.07B | $6.30B |
| Gross margin | 40.3% | 45.9% | 52.8% | 54.5% | 31.9% | 26.4% | 35.3% |
| Operating income | $9.75M | $10.3M | $13.6M | −$7.02M | −$3.97B | −$8.02B | −$2.92B |
| Operating margin | 29.4% | 33.4% | 28.3% | −17.5% | −12.3% | −34.8% | −16.3% |
| Net income | $7.55M | $7.56M | $11.3M | −$7.91M | −$6.58B | −$8.73B | −$3.67B |
| Net margin | 22.7% | 24.6% | 23.6% | −19.7% | −20.4% | −37.9% | −20.6% |
| EPS (diluted) | $16.92 | $2.82 | $3.58 | −$1309.11 | −$1089.21 | −$626.96 | −$8.06 |
| Balance sheet | |||||||
| Cash and equivalents | $3.18M | $10.1M | $8.08M | $5.71B | $5.29B | $29.5B | $33.6B |
| Total assets | — | $28.8M | $70.1M | $59.5M | $41.7M | $68.0B | $69.3B |
| Total liabilities | — | $8.00M | $23.2M | −$35.3B | $13.8M | $22.5B | $13.2B |
| Shareholders' equity | $12.4M | $20.8M | $47.0M | — | — | $45.5B | $56.1B |
| Cash flow | |||||||
| Operating cash flow | $13.2M | $6.12M | −$2.06M | −$1.30M | $1.12B | −$9.51B | −$5.05B |
| Capital expenditure | $86.3K | $51.8K | $444.5K | $93.7K | $44.2M | $208.3M | $266.8M |
| Free cash flow | $13.1M | $6.06M | −$2.50M | −$1.40M | $1.07B | −$9.72B | −$5.32B |
| Dividends paid | $16.0M | — | — | — | — | — | — |
From Universe Pharmaceuticals's 20-F and 6-K filings with the SEC; its fiscal year ends in September. Each period shows the latest figure the company has reported for it, including restatements. Per-share figures are per ordinary share, which is not always the share traded in the US: an ADS can stand for several, or for part of one. Filings on SEC EDGAR →
No recent news mentioning Universe Pharmaceuticals in our feed yet.